antipyrine has been researched along with Acute Brain Injuries in 32 studies
Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.
Excerpt | Relevance | Reference |
---|---|---|
" This study was designed to evaluate the protective effect of edaravone, a free radical scavenger, on radiation-induced brain necrosis in patients with nasopharyngeal carcinoma." | 9.19 | Effect of edaravone on radiation-induced brain necrosis in patients with nasopharyngeal carcinoma after radiotherapy: a randomized controlled trial. ( Hu, W; Li, G; Luo, J; Rong, X; Tang, Y; Xu, P; Yang, J; Yang, X, 2014) |
" This study was designed to evaluate the protective effect of edaravone, a free radical scavenger, on radiation-induced brain necrosis in patients with nasopharyngeal carcinoma." | 5.19 | Effect of edaravone on radiation-induced brain necrosis in patients with nasopharyngeal carcinoma after radiotherapy: a randomized controlled trial. ( Hu, W; Li, G; Luo, J; Rong, X; Tang, Y; Xu, P; Yang, J; Yang, X, 2014) |
"The edaravone-treated animals also exhibited higher rCBF in the contralateral hemisphere compared with that seen in -vehicle-treated animals." | 1.39 | Edaravone increases regional cerebral blood flow after traumatic brain injury in mice. ( Aruga, T; Dohi, K; Kiriyama, K; Miyamoto, K; Nakano, H; Ohtaki, H; Shioda, S; Song, D; Tsumuraya, T, 2013) |
"Edaravone treatment significantly decreased hippocampal CA3 neuron loss, reduced oxidative stress, and decreased neuronal programmed cell death compared to vehicle treatment." | 1.37 | Free-radical scavenger edaravone treatment confers neuroprotection against traumatic brain injury in rats. ( Chen, J; Gao, YQ; Jiang, ZL; Li, X; Li, YC; Shi, H; Vosler, PS; Wang, GH, 2011) |
"Edaravone is a novel free radical scavenger used clinically in patients with acute cerebral infarction; however, it has not been assessed in traumatic brain injury (TBI)." | 1.36 | Edaravone protects against apoptotic neuronal cell death and improves cerebral function after traumatic brain injury in rats. ( Hashimoto, S; Imano, M; Ito, H; Itoh, T; Nishida, S; Satou, T; Tsubaki, M, 2010) |
"Edaravone is a novel free radical scavenger that is clinically employed in patients with acute cerebral infarction, but has not previously been used to treat traumatic brain injury (TBI)." | 1.35 | The novel free radical scavenger, edaravone, increases neural stem cell number around the area of damage following rat traumatic brain injury. ( Hashimoto, S; Ito, H; Itoh, T; Nishida, S; Satou, T; Tsubaki, M, 2009) |
"Edaravone (MCI-186) is a novel synthetic free radical scavenger intended to have neuroprotective effect against ischemic insult." | 1.34 | Does edaravone (MCI- 186) act as an antioxidant and a neuroprotector in experimental traumatic brain injury? ( Aruga, T; Dohi, K; Hiratsuka, K; Nakamachi, T; Nakamura, S; Ohtaki, H; Satoh, K; Shioda, S; Yofu, S; Yoshikawa, T, 2007) |
"At 24 h, hyperemia was observed (vs." | 1.29 | Posttraumatic hyperemia in immature, mature, and aged rats: autoradiographic determination of cerebral blood flow. ( Biagas, KV; Grundl, PD; Kochanek, PM; Nemoto, EM; Schiding, JK, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (15.63) | 18.7374 |
1990's | 2 (6.25) | 18.2507 |
2000's | 14 (43.75) | 29.6817 |
2010's | 10 (31.25) | 24.3611 |
2020's | 1 (3.13) | 2.80 |
Authors | Studies |
---|---|
Kara, O | 1 |
Kilitci, A | 1 |
Miyamoto, K | 2 |
Ohtaki, H | 4 |
Dohi, K | 4 |
Tsumuraya, T | 2 |
Nakano, H | 1 |
Kiriyama, K | 2 |
Song, D | 2 |
Aruga, T | 4 |
Shioda, S | 4 |
Satoh, K | 3 |
Shimizu, A | 1 |
Tang, Y | 1 |
Rong, X | 1 |
Hu, W | 1 |
Li, G | 1 |
Yang, X | 1 |
Yang, J | 1 |
Xu, P | 1 |
Luo, J | 1 |
Qin, T | 1 |
Lei, LY | 1 |
Li, N | 1 |
Shi, FR | 1 |
Chen, MH | 1 |
Xie, L | 1 |
Engel, DC | 1 |
Mies, G | 1 |
Terpolilli, NA | 1 |
Trabold, R | 1 |
Loch, A | 1 |
De Zeeuw, CI | 1 |
Weber, JT | 1 |
Maas, AI | 1 |
Plesnila, N | 1 |
Itoh, T | 2 |
Satou, T | 2 |
Nishida, S | 2 |
Tsubaki, M | 2 |
Hashimoto, S | 2 |
Ito, H | 2 |
Imano, M | 1 |
Gao, Y | 1 |
Ding, XS | 1 |
Xu, S | 1 |
Wang, W | 1 |
Zuo, QL | 1 |
Kuai, F | 1 |
Zhao, YN | 1 |
Guo, X | 1 |
Gao, JL | 1 |
Chen, HH | 1 |
Tian, YX | 1 |
Cui, JZ | 1 |
Lukic-Panin, V | 1 |
Deguchi, K | 1 |
Yamashita, T | 1 |
Shang, J | 1 |
Zhang, X | 1 |
Tian, F | 1 |
Liu, N | 1 |
Kawai, H | 1 |
Matsuura, T | 1 |
Abe, K | 1 |
Wang, GH | 1 |
Jiang, ZL | 1 |
Li, YC | 1 |
Li, X | 1 |
Shi, H | 1 |
Gao, YQ | 1 |
Vosler, PS | 1 |
Chen, J | 1 |
Yamashita, S | 1 |
Hasuo, H | 1 |
Tokutomi, T | 1 |
Shigemori, M | 1 |
Akasu, T | 1 |
Ohta, M | 1 |
Higashi, Y | 1 |
Yawata, T | 1 |
Kitahara, M | 1 |
Nobumoto, A | 1 |
Ishida, E | 1 |
Tsuda, M | 1 |
Fujimoto, Y | 1 |
Shimizu, K | 1 |
KOVALEVA, NT | 1 |
ALLIEZ, J | 1 |
MOUREN, P | 1 |
CARCASSONNE, Y | 1 |
AYMES, G | 1 |
GEBHARDT, KH | 1 |
Nakamura, H | 1 |
Uzura, M | 1 |
Uchida, K | 1 |
Nakayama, H | 1 |
Furuya, Y | 1 |
Hayashi, T | 1 |
Sekino, H | 1 |
Ominato, M | 1 |
Owada, S | 1 |
Chen, SF | 1 |
Richards, HK | 2 |
Smielewski, P | 1 |
Johnström, P | 1 |
Salvador, R | 1 |
Pickard, JD | 2 |
Harris, NG | 1 |
Zhang, LH | 1 |
Wei, EQ | 2 |
Maeda, T | 1 |
Lee, SM | 2 |
Hovda, DA | 2 |
Ding, Q | 1 |
Zhang, YJ | 1 |
Zhang, WP | 1 |
Chen, Z | 1 |
Mihara, Y | 1 |
Nakamura, S | 2 |
Miyake, Y | 1 |
Nakamachi, T | 2 |
Yoshikawa, T | 2 |
Yofu, S | 1 |
Hiratsuka, K | 1 |
Masaoka, N | 1 |
Nakajima, Y | 1 |
Watanabe, M | 1 |
Hayakawa, Y | 1 |
Nagaishi, M | 1 |
Yamamoto, T | 1 |
Honma, T | 1 |
Oinuma, T | 1 |
Nemoto, N | 1 |
Scremin, OU | 1 |
Li, MG | 1 |
Scremin, AM | 1 |
Dietrich, WD | 1 |
Alonso, O | 1 |
Busto, R | 1 |
Prado, R | 1 |
Dewanjee, S | 1 |
Dewanjee, MK | 1 |
Ginsberg, MD | 1 |
Biagas, KV | 1 |
Grundl, PD | 1 |
Kochanek, PM | 1 |
Schiding, JK | 1 |
Nemoto, EM | 1 |
Kelly, DF | 1 |
Kozlowski, DA | 1 |
Haddad, E | 1 |
Echiverri, A | 1 |
Simac, S | 1 |
Piechnik, S | 1 |
Milhorat, TH | 1 |
Johnson, WD | 1 |
Dow-Edwards, DL | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis in Patients With Nasopharyngeal Carcinoma After Radiotherapy[NCT01865201] | Phase 2 | 154 participants (Actual) | Interventional | 2009-03-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for antipyrine and Acute Brain Injuries
Article | Year |
---|---|
Effect of edaravone on radiation-induced brain necrosis in patients with nasopharyngeal carcinoma after radiotherapy: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antipyrine; Brain Injuries; Carcinoma; Case-Control Studies; Edaravo | 2014 |
31 other studies available for antipyrine and Acute Brain Injuries
Article | Year |
---|---|
Antioxidant and Apoptotic Effect of Edaravone on Cisplatin-Induced Brain Injury in Rats.
Topics: Animals; Antioxidants; Antipyrine; Brain Injuries; Cisplatin; Edaravone; Female; Free Radical Scaven | 2024 |
Edaravone increases regional cerebral blood flow after traumatic brain injury in mice.
Topics: Animals; Antipyrine; Brain; Brain Injuries; Cerebrovascular Circulation; Disease Models, Animal; Eda | 2013 |
Therapeutic time window for edaravone treatment of traumatic brain injury in mice.
Topics: Animals; Antipyrine; Brain Injuries; Disease Models, Animal; Edaravone; Free Radical Scavengers; Jap | 2013 |
Edaravone improves survival and neurological outcomes after CPR in a ventricular fibrillation model of rats.
Topics: Animals; Antipyrine; Brain Injuries; Cardiopulmonary Resuscitation; Disease Models, Animal; Edaravon | 2016 |
Changes of cerebral blood flow during the secondary expansion of a cortical contusion assessed by 14C-iodoantipyrine autoradiography in mice using a non-invasive protocol.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Autoradiography; Biomarkers; Brain; Br | 2008 |
The novel free radical scavenger, edaravone, increases neural stem cell number around the area of damage following rat traumatic brain injury.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult Stem Cells; Aldehydes; Animals; Antipyrine; Behavior, Animal; Bra | 2009 |
Edaravone protects against apoptotic neuronal cell death and improves cerebral function after traumatic brain injury in rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehydes; Animals; Antipyrine; Apoptosis; Behavior, Animal; Brain Inju | 2010 |
Neuroprotective effects of edaravone on early brain injury in rats after subarachnoid hemorrhage.
Topics: Animals; Antipyrine; Blotting, Western; Brain Injuries; Edaravone; Immunohistochemistry; Male; Malon | 2009 |
[Effect of edaravone on extracellular signal-regulated kinase 1/2 pathway following severe traumatic brain injury in rats].
Topics: Animals; Antipyrine; Apoptosis; Brain Injuries; Disease Models, Animal; Edaravone; Male; Mitogen-Act | 2010 |
Free radical scavenger edaravone administration protects against tissue plasminogen activator induced oxidative stress and blood brain barrier damage.
Topics: Acetylglucosamine; Animals; Antipyrine; Blood-Brain Barrier; Brain Injuries; Cerebral Cortex; Collag | 2010 |
Free-radical scavenger edaravone treatment confers neuroprotection against traumatic brain injury in rats.
Topics: Animals; Antipyrine; Apoptosis; Astrocytes; Blood-Brain Barrier; Body Water; Brain Injuries; Colorin | 2011 |
Edaravone attenuates impairment of synaptic plasticity in granule cell layer of the dentate gyrus following traumatic brain injury.
Topics: Animals; Antipyrine; Brain Injuries; Dentate Gyrus; Edaravone; Electric Stimulation; Excitatory Post | 2011 |
Attenuation of axonal injury and oxidative stress by edaravone protects against cognitive impairments after traumatic brain injury.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antipyrine; Brain Injuries; Cognition; Cognition Disorders; De | 2013 |
[Commotional experimental hypertension].
Topics: Antipyrine; Brain; Brain Injuries; Humans; Hypertension | 1952 |
[Post-commotional Korsakoff syndrome with initial mesodiencephalic dysrhythmia; systematic failure of recognition through elective retrograde amnesia].
Topics: Amnesia; Amnesia, Retrograde; Antipyrine; Brain; Brain Injuries; Electroencephalography; Humans; Kor | 1953 |
[Posttraumatic subjective syndrome with hybrid post cervical sympathetic commotional syndrome (Pierre-Marie; Barre-Lieou)].
Topics: Antipyrine; Brain; Brain Injuries; Cervical Plexus; Disease; Horner Syndrome; Wounds and Injuries | 1955 |
[Review of post-commotional brain injuries and the length of therapy].
Topics: Antipyrine; Brain; Brain Injuries; Diabetes Insipidus; Diabetes Insipidus, Neurogenic; Humans | 1957 |
Effects of edaravone on experimental brain injury in view of free radical reaction.
Topics: Animals; Antipyrine; Body Water; Brain; Brain Edema; Brain Injuries; Edaravone; Electron Spin Resona | 2003 |
Relationship between flow-metabolism uncoupling and evolving axonal injury after experimental traumatic brain injury.
Topics: Amyloid beta-Protein Precursor; Animals; Antipyrine; Autoradiography; Axons; Brain Injuries; Carbon | 2004 |
ONO-1078 reduces NMDA-induced brain injury and vascular cell adhesion molecule-1 expression in rats.
Topics: Animals; Antipyrine; Brain; Brain Injuries; Cerebral Cortex; Chromones; Edaravone; Leukotriene Antag | 2005 |
Restoration of cerebral vasoreactivity by an L-type calcium channel blocker following fluid percussion brain injury.
Topics: Animals; Antipyrine; Blood Pressure; Brain Injuries; Calcium; Calcium Channel Blockers; Calcium Chan | 2005 |
Cysteinyl leukotriene receptor 1 is involved in N-methyl-D-aspartate-mediated neuronal injury in mice.
Topics: Animals; Antioxidants; Antipyrine; Brain; Brain Injuries; Chromones; Edaravone; Ketamine; Male; Memb | 2006 |
Alkoxyl radical-scavenging activity of edaravone in patients with traumatic brain injury.
Topics: Adult; Alcohols; Antipyrine; Brain Injuries; Edaravone; Electron Spin Resonance Spectroscopy; Female | 2006 |
Does edaravone (MCI- 186) act as an antioxidant and a neuroprotector in experimental traumatic brain injury?
Topics: alpha-Tocopherol; Animals; Antioxidants; Antipyrine; Blood; Brain Injuries; Edaravone; Free Radical | 2007 |
MCI-186 administered to the maternal circulation inhibits fetal brain injury resulting from total umbilical cord occlusion in the chronically instrumented fetal lamb.
Topics: Animals; Antipyrine; Brain Injuries; Edaravone; Female; Fetal Hypoxia; Free Radical Scavengers; Mate | 2006 |
Cortical contusion induces trans-hemispheric reorganization of blood flow maps.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Brain Injuries; | 2007 |
Widespread hemodynamic depression and focal platelet accumulation after fluid percussion brain injury: a double-label autoradiographic study in rats.
Topics: Animals; Antipyrine; Autoradiography; Blood Platelets; Brain Injuries; Carbon Radioisotopes; Cerebro | 1996 |
Posttraumatic hyperemia in immature, mature, and aged rats: autoradiographic determination of cerebral blood flow.
Topics: Adult; Aging; Animals; Antipyrine; Autoradiography; Brain; Brain Injuries; Carbon Radioisotopes; Cer | 1996 |
Ethanol reduces metabolic uncoupling following experimental head injury.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antipyrine; Autoradiography; Brain Injuries; Carbo | 2000 |
Uncoupling of cerebral blood flow and metabolism after cerebral contusion in the rat.
Topics: Animals; Antipyrine; Autoradiography; Brain; Brain Chemistry; Brain Injuries; Carbon Radioisotopes; | 2001 |
Relationship between oedema, blood pressure, and blood flow following local brain injury.
Topics: Animals; Antipyrine; Blood Pressure; Brain Edema; Brain Injuries; Cerebrovascular Circulation; Male; | 1989 |